Charles River Laboratories International, Inc. NYSE:CRL

Charles River Laboratories International stock price today

$158.6
-27.56
-14.8%
Financial Health
0
1
2
3
4
5
6
7
8
9

Charles River Laboratories International stock price monthly change

-13.89%
month

Charles River Laboratories International stock price quarterly change

-13.89%
quarter

Charles River Laboratories International stock price yearly change

-22.06%
year

Charles River Laboratories International key metrics

Market Cap
9.50B
Enterprise value
13.16B
P/E
21.28
EV/Sales
3.31
EV/EBITDA
13.43
Price/Sales
2.59
Price/Book
3.46
PEG ratio
0.91
EPS
8.66
Revenue
4.11B
EBITDA
1.01B
Income
438.82M
Revenue Q/Q
-1.73%
Revenue Y/Y
0.49%
Profit margin
12.23%
Oper. margin
16.37%
Gross margin
36.79%
EBIT margin
16.37%
EBITDA margin
24.76%
Sign up &
create your own Smart Feed

Personalize your watchlist with companies you want to keep track of and get notified in the smart feed every time fresh news arrives.

Sign up for free

Charles River Laboratories International stock price history

Charles River Laboratories International stock forecast

Charles River Laboratories International financial statements

Average Price Target
Last Year

$201.5

Potential upside: 27.04%

Based on estimate of 4 analysts
  • Analysts Price target

  • Financials & Ratios estimates

Charles River Laboratories International, Inc. (NYSE:CRL): Profit margin
Jul 2023 1.05B 97.02M 9.15%
Sep 2023 1.02B 87.38M 8.51%
Dec 2023 1.01B 187.08M 18.46%
Mar 2024 1.01B 67.32M 6.66%
Charles River Laboratories International, Inc. (NYSE:CRL): Debt to assets
Jul 2023 7772381000 4.47B 57.54%
Sep 2023 7607007000 4.25B 55.95%
Dec 2023 8195001000 4.53B 55.35%
Mar 2024 8152783000 4.44B 54.57%
Charles River Laboratories International, Inc. (NYSE:CRL): Cash Flow
Jul 2023 148.12M -76.60M -71.46M
Sep 2023 205.45M -79.55M -162.86M
Dec 2023 220.94M -238.37M 123.56M
Mar 2024 129.88M -85.79M 18.34M

Charles River Laboratories International alternative data

Charles River Laboratories International Social Media Accounts

What are followers?
Charles River Laboratories International, Inc. (NYSE:CRL): Followers count
May 2025 5294
Jul 2025 5352
Aug 2025 5374

Charles River Products and Services

Charles River Laboratories International, Inc. (NYSE:CRL): Google Trends - Charles River Products and Services
12 Feb 2023 048
19 Feb 2023 051
26 Feb 2023 057
5 Mar 2023 067
12 Mar 2023 161
19 Mar 2023 168
26 Mar 2023 167
2 Apr 2023 062
9 Apr 2023 057
16 Apr 2023 049
23 Apr 2023 048
30 Apr 2023 041
7 May 2023 049
14 May 2023 049
21 May 2023 052
28 May 2023 051
4 Jun 2023 149
11 Jun 2023 047
18 Jun 2023 044
25 Jun 2023 050

Numbers represent search interest relative to the highest point on the chart for the given region and time.

A value of 100 is the peak popularity for the term.
A value of 50 means that the term is half as popular.
A score of 0 means there was not enough data for this term.

Charles River Laboratories International, Inc. (NYSE:CRL): Job openings
Aug 2023 359
Sep 2023 378
Oct 2023 372
Nov 2023 385
Dec 2023 346
Jan 2024 327
Feb 2024 322
Apr 2024 307
May 2024 369
Jun 2024 356
Jul 2024 351
Dec 2024 252
Charles River Laboratories International, Inc. (NYSE:CRL): Employee count
Aug 2023 20,000
Sep 2023 20,000
Oct 2023 20,000
Nov 2023 20,000
Dec 2023 20,000
Jan 2024 20,000
Feb 2024 20,000
Mar 2024 20,400
Apr 2024 20,400
May 2024 20,400
Jun 2024 20,400
Jul 2024 20,400

Charles River Laboratories International other data

94.03% +2.45%
of CRL is owned by hedge funds
48.22M +1.21M
shares is hold by hedge funds

Charles River Laboratories International, Inc. (NYSE:CRL): Insider trades (number of shares)
Period Buy Sel
Aug 2023 1000 7934
Nov 2023 6942 10978
Dec 2023 0 5526
Feb 2024 0 19556
Mar 2024 0 3558
May 2024 0 1636
Transaction Date Insider Security Shares Price per share Total value Source
Sale
MASSARO GEORGE director
Common Stock 123 $234.72 $28,871
Sale
MASSARO GEORGE director
Common Stock 113 $235.61 $26,624
Sale
MASSARO GEORGE director
Common Stock 96 $236.78 $22,731
Sale
LAPLUME JOSEPH W officer: EVP, Cor.. Common Stock 1,304 $226.97 $295,969
Sale
KNELL MICHAEL GUNNAR officer: CSVP&Chief Accounting ..
Common Stock 808 $267.52 $216,156
Sale
KNELL MICHAEL GUNNAR officer: CSVP&Chief Accounting ..
Common Stock 1,750 $260.88 $456,540
Sale
KNELL MICHAEL GUNNAR officer: CSVP&Chief Accounting ..
Common Stock 1,000 $261.35 $261,350
Sale
PARISOTTO SHANNON M officer: CEVP, Disc & Safety As..
Common Stock 100 $254.02 $25,402
Sale
PARISOTTO SHANNON M officer: CEVP, Disc & Safety As..
Common Stock 3,686 $253.43 $934,143
Sale
CREAMER VICTORIA L officer: EVP & Chief People Off..
Common Stock 5,000 $253.7 $1,268,500
Patent
Application
Filling date: 26 Apr 2022 Issue date: 11 Aug 2022
Application
Filling date: 31 Jan 2022 Issue date: 19 May 2022
Grant
Filling date: 18 Sep 2018 Issue date: 8 Mar 2022
Application
Filling date: 5 Mar 2021 Issue date: 24 Jun 2021
Application
Filling date: 18 Feb 2021 Issue date: 24 Jun 2021
Grant
Filling date: 1 Jun 2016 Issue date: 23 Mar 2021
Tuesday, 17 December 2024
zacks.com
Monday, 9 December 2024
zacks.com
Friday, 6 December 2024
zacks.com
Thursday, 5 December 2024
businesswire.com
Thursday, 28 November 2024
zacks.com
Monday, 11 November 2024
zacks.com
Wednesday, 6 November 2024
seekingalpha.com
zacks.com
zacks.com
zacks.com
reuters.com
Wednesday, 30 October 2024
zacks.com
Tuesday, 29 October 2024
zacks.com
Tuesday, 22 October 2024
zacks.com
Friday, 18 October 2024
zacks.com
Thursday, 17 October 2024
businesswire.com
Wednesday, 16 October 2024
businesswire.com
Thursday, 10 October 2024
zacks.com
Tuesday, 8 October 2024
businesswire.com
Thursday, 19 September 2024
businesswire.com
Wednesday, 18 September 2024
zacks.com
globenewswire.com
Monday, 9 September 2024
zacks.com
Friday, 6 September 2024
zacks.com
Thursday, 22 August 2024
globenewswire.com
Thursday, 15 August 2024
seekingalpha.com
Tuesday, 13 August 2024
globenewswire.com
Monday, 12 August 2024
zacks.com
Saturday, 10 August 2024
seekingalpha.com
Wednesday, 7 August 2024
zacks.com
  • What's the price of Charles River Laboratories International stock today?

    One share of Charles River Laboratories International stock can currently be purchased for approximately $158.6.

  • When is Charles River Laboratories International's next earnings date?

    Unfortunately, Charles River Laboratories International's (CRL) next earnings date is currently unknown.

  • Does Charles River Laboratories International pay dividends?

    No, Charles River Laboratories International does not pay dividends.

  • How much money does Charles River Laboratories International make?

    Charles River Laboratories International has a market capitalization of 9.50B and it's past years’ income statements indicate that its last revenue has increased compared to the previous period by 3.86% to 4.13B US dollars.

  • What is Charles River Laboratories International's stock symbol?

    Charles River Laboratories International, Inc. is traded on the NYSE under the ticker symbol "CRL".

  • What is Charles River Laboratories International's primary industry?

    Company operates in the Healthcare sector and Medical - Diagnostics & Research industry.

  • How do i buy shares of Charles River Laboratories International?

    Shares of Charles River Laboratories International can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

  • Who are Charles River Laboratories International's key executives?

    Charles River Laboratories International's management team includes the following people:

    • Mr. James C. Foster Chairman, Chief Executive Officer & Pres(age: 74, pay: $3,070,000)
    • Mr. David Ross Smith Corporation Executive Vice President & Chief Financial Officer(age: 59, pay: $1,180,000)
    • Mr. William D. Barbo Chief Commercial Officer & Corporation Executive Vice President(age: 64, pay: $994,680)
    • Mr. Joseph W. LaPlume Corporation Executive Vice President of Corporation Devel. & Strategy(age: 51, pay: $941,780)
    • Ms. Birgit Girshick Corporation Executive Vice President & Chief Operating Officer(age: 55, pay: $912,920)
  • How many employees does Charles River Laboratories International have?

    As Jul 2024, Charles River Laboratories International employs 20,400 workers.

  • When Charles River Laboratories International went public?

    Charles River Laboratories International, Inc. is publicly traded company for more then 25 years since IPO on 23 Jun 2000.

  • What is Charles River Laboratories International's official website?

    The official website for Charles River Laboratories International is criver.com.

  • Where are Charles River Laboratories International's headquarters?

    Charles River Laboratories International is headquartered at 251 Ballardvale Street, Wilmington, MA.

  • How can i contact Charles River Laboratories International?

    Charles River Laboratories International's mailing address is 251 Ballardvale Street, Wilmington, MA and company can be reached via phone at +7 812226000.

  • What is Charles River Laboratories International stock forecast & price target?

    Based on 4 Wall Street analysts` predicted price targets for Charles River Laboratories International in the last 12 months, the avarage price target is $201.5. The average price target represents a 27.04% change from the last price of $158.6.

Charles River Laboratories International company profile:

Charles River Laboratories International, Inc.

criver.com
Exchange:

NYSE

Full time employees:

20,400

Industry:

Medical - Diagnostics & Research

Sector:

Healthcare

Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Assessment (DSA), and Manufacturing Solutions (Manufacturing). The RMS segment produces and sells rodent research model strains and purpose-bred rats and mice for use by researchers. This segment also provides a range of services to assist its clients in supporting the use of research models in research and screening non-clinical drug candidates, including research models, genetically engineered models and services, insourcing solutions, and research animal diagnostic services. The DSA segment offers early and in vivo discovery services for the identification and validation of novel targets, chemical compounds, and antibodies through delivery of non-clinical drug and therapeutic candidates ready for safety assessment; and safety assessment services, such as toxicology, pathology, safety pharmacology, bioanalysis, drug metabolism, and pharmacokinetics services. The Manufacturing segment provides in vitro methods for conventional and rapid quality control testing of sterile and non-sterile pharmaceuticals and consumer products. This segment also offers specialized testing of biologics that are outsourced by pharmaceutical and biotechnology companies; and avian vaccine services that provide specific-pathogen-free (SPF) fertile chicken eggs, SPF chickens, and diagnostic products used to manufacture vaccines. The company also provides contract vivarium operation services to biopharmaceutical clients. Charles River Laboratories International, Inc. was founded in 1947 and is headquartered in Wilmington, Massachusetts.

251 Ballardvale Street
Wilmington, MA 01887

CIK: 0001100682
ISIN: US1598641074
CUSIP: 159864107